Home›Stock Screener›Aspira Pathlab›Intrinsic Value

Aspira Pathlab Intrinsic Value

Aspira Pathlab intrinsic value. Aspira Pathlab (ASPIRA) median intrinsic value is ₹48.00 from 9 valuation models (range ₹26–₹66), vs current price ₹131.00 — -63.4% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse Aspira Pathlab ownership structure to track promoter, FII and institutional holdings.

Market Price (CMP)
₹131.00
Primary Intrinsic Value
₹58.08
Market Cap
₹131.0 Cr
-63.4% Downside
Median Value
₹48.00
Value Range
₹26 - ₹66
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

ASPIRA Valuation Methods Summary — DCF, Graham Number & P/E

Aspira Pathlab intrinsic value across 9 models vs current price ₹131.00 — upside/downside and value range per method. For current market price and key ratios, visit Aspira Pathlab stock price NSE.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹58.08 ₹46.46 - ₹69.70 -55.7% EPS: ₹2.64, Sector P/E: 22x
Book Value Method asset ₹26.20 ₹23.58 - ₹28.82 -80.0% Book Value/Share: ₹12.00, P/B: 2.0x
Revenue Multiple Method revenue ₹48.00 ₹43.20 - ₹52.80 -63.4% Revenue/Share: ₹24.00, P/S: 2.0x
EBITDA Multiple Method earnings ₹52.40 ₹47.16 - ₹57.64 -60.0% EBITDA: ₹4.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹52.40 ₹41.92 - ₹62.88 -60.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹39.30 ₹35.37 - ₹43.23 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹40.79 ₹36.71 - ₹44.87 -68.9% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹65.50 ₹58.95 - ₹72.05 -50.0% ROE: 33.3%, P/E Multiple: 16x
Graham Defensive Method conservative ₹39.30 ₹35.37 - ₹43.23 -70.0% EPS: ₹2.64, BVPS: ₹12.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

ASPIRA Intrinsic Value vs Market Price — All Valuation Models

Aspira Pathlab fair value range ₹26–₹66 vs current market price ₹131.00 across 9 valuation models. Browse Aspira Pathlab financial data for revenue, profit, balance sheet and cash flow data.

ASPIRA Intrinsic Value Analysis — Undervalued or Overvalued?

Aspira Pathlab median intrinsic value ₹48.00, current price ₹131.00 — Trading Above Calculated Value by 63.4%, margin of safety -100.0%.

What is the intrinsic value of ASPIRA?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Aspira Pathlab (ASPIRA) is ₹48.00 (median value). With the current market price of ₹131.00, this represents a -63.4% variance from our estimated fair value.

The valuation range spans from ₹26.20 to ₹65.50, indicating ₹26.20 - ₹65.50.

Is ASPIRA undervalued or overvalued?

Based on our multi-method analysis, Aspira Pathlab (ASPIRA) appears to be trading above calculated value by approximately 63.4%.

ASPIRA Financial Health — Key Ratios vs Industry Benchmarks

Aspira Pathlab financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 33.3% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 16.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.33x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

ASPIRA Cash Flow Quality — Operating & Free Cash Flow

Aspira Pathlab operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2024 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10